SHC
Overvalued by 153.1% based on the discounted cash flow analysis.
Market cap | $3.21 Billion |
---|---|
Enterprise Value | $5.27 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $0.19 |
Beta | 0.9 |
Outstanding Shares | 283,070,826 |
Avg 30 Day Volume | 1,185,211 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 58.47 |
---|---|
PEG | 47.49 |
Price to Sales | 3.68 |
Price to Book Ratio | 11.04 |
Enterprise Value to Revenue | 4.89 |
Enterprise Value to EBIT | 17.77 |
Enterprise Value to Net Income | 96 |
Total Debt to Enterprise | 0.44 |
Debt to Equity | 5.41 |
No data
No data
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses - Sterigen...